Population pharmacokinetic modeling of sertraline treatment in patients with Alzheimer disease: the DIADS-2 study

J Clin Pharmacol. 2013 Feb;53(2):234-9. doi: 10.1177/0091270012445793. Epub 2013 Jan 24.
No abstract available

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / blood*
  • Alzheimer Disease / drug therapy
  • Antidepressive Agents / blood
  • Antidepressive Agents / pharmacokinetics*
  • Depression / blood*
  • Depression / drug therapy
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Models, Biological*
  • Selective Serotonin Reuptake Inhibitors / blood
  • Selective Serotonin Reuptake Inhibitors / pharmacokinetics*
  • Sertraline / blood
  • Sertraline / pharmacokinetics*

Substances

  • Antidepressive Agents
  • Serotonin Uptake Inhibitors
  • Sertraline